Pegvisomant in acromegaly: a multicenter real-life study in Argentina

Autor: Analía Pignatta, Adriana Frigeri, Laura R. Sago, Natalia Garcia Basavilbaso, Marisa Servidio, Rodolfo Guelman, Nicolas Marcelo Vitale, Gabriel Isaac, Darío Bruera, Silvina Gabriela Fidalgo, Mirtha Guitelman, Oscar D. Bruno, Alberto Chervin, Paula Szafryk de Mereshian, Fabiana Librandi, Daniel Moncet, Marcos Manavela, Mariela Glerean, Monica Spezzi, Débora Katz, Pablo Knoblovits, Patricia Fainstein-Day, Julieta Tkatch, Graciela Stalldecker, Karina Danilowicz, Monica López Montes, Amelia Rogozinsky, Maria Carolina Ballarino, María Susana Mallea-Gil

Publikováno v: Archives of Endocrinology and Metabolism, Volume: 63, Issue: 4, Pages: 320-327, Published: 22 AUG 2019
Archives of Endocrinology and Metabolism, Vol 63, Iss 4, Pp 320-327
Archives of Endocrinology and Metabolism v.63 n.4 2019
Arquivos de Endocrinologia e Metabolismo
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
instacron:SBEM

Objective To describe the long term safety and efficacy of pegvisomant (PEGV), and the predictors of treatment response in patients with acromegaly in the real life setting. Subjects and methods We retrospectively reviewed the clinical, hormonal and

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::106aacc89fa47c7414d0565d361889c3
https://doi.org/10.20945/2359-3997000000160

MON-LB090 Red-Hipopara, Real Life Experience in 322 Patients with Hypoparathyroidism in Argentina

Autor: Adriana Graciela Díaz, Sabrina Lucas, Beatriz Oliveri, S. Tormo, H. Salerni, Evangelina Giacoia, Mariela Kitaigrodsky, Adriana Frigeri, Betiana Perez, Matias Grandjean, A.M. Galich, Silvia Kallsbrum, María Belén Zanchetta, Damian Robbiani

Publikováno v: Journal of the Endocrine Society

Hypoparathyroidism (HPT) is a rare disorder characterized by hypocalcemia and absent or deficient PTH. Few data are available on the natural history and correct management of this disease. Aim: Describe clinical characteristics, treatment, and compli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::451580c6e966e9a2328bf2ea73ec5dd9
https://doi.org/10.1210/js.2019-mon-lb090

Tolerability of oral pamidronate in elderly patients with osteoporosis and other metabolic bone diseases

Autor: Roxana Fiasché, Francisco R Spivacow, Eduardo M. Kerzberg, JoséR. Zanchetta, Emilio J.A. Roldán, Adriana Frigeri

Publikováno v: Current Therapeutic Research. 57:123-130

Oral pamidronate (APD) is being used increasingly in the treatment of a variety of bone diseases. In a retrospective chart review of patients at three research centers (a 558.3 patient-year sample), the side effects of treatment with oral, low-dose A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9717bb87f32005fc4de68b02c388c4a2
https://doi.org/10.1016/s0011-393x(96)80006-3